DK0714306T3 - Inaktiveret respiratorisk syncytialvirus-vacciner - Google Patents

Inaktiveret respiratorisk syncytialvirus-vacciner

Info

Publication number
DK0714306T3
DK0714306T3 DK94923619T DK94923619T DK0714306T3 DK 0714306 T3 DK0714306 T3 DK 0714306T3 DK 94923619 T DK94923619 T DK 94923619T DK 94923619 T DK94923619 T DK 94923619T DK 0714306 T3 DK0714306 T3 DK 0714306T3
Authority
DK
Denmark
Prior art keywords
virus
inactivated
immunogenic composition
respiratory syncytial
purified
Prior art date
Application number
DK94923619T
Other languages
Danish (da)
English (en)
Inventor
Sonia E Sanhueza
Mary Elizabeth Ewasyshyn
Michel Henri Klein
Original Assignee
Connaught Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Connaught Lab filed Critical Connaught Lab
Application granted granted Critical
Publication of DK0714306T3 publication Critical patent/DK0714306T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18551—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
DK94923619T 1993-08-06 1994-08-04 Inaktiveret respiratorisk syncytialvirus-vacciner DK0714306T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10274293A 1993-08-06 1993-08-06
PCT/CA1994/000425 WO1995004545A1 (en) 1993-08-06 1994-08-04 Inactivated respiratory syncytial viral vaccines

Publications (1)

Publication Number Publication Date
DK0714306T3 true DK0714306T3 (da) 1998-10-19

Family

ID=22291469

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94923619T DK0714306T3 (da) 1993-08-06 1994-08-04 Inaktiveret respiratorisk syncytialvirus-vacciner

Country Status (15)

Country Link
US (1) US7083795B1 (ko)
EP (1) EP0714306B1 (ko)
JP (1) JP4053587B2 (ko)
KR (1) KR100402379B1 (ko)
CN (1) CN1103603C (ko)
AT (1) ATE164313T1 (ko)
AU (1) AU677090B2 (ko)
BR (1) BR9407182A (ko)
CA (1) CA2167274C (ko)
DE (1) DE69409243T2 (ko)
DK (1) DK0714306T3 (ko)
ES (1) ES2113670T3 (ko)
GR (1) GR3026619T3 (ko)
RU (1) RU2142817C1 (ko)
WO (1) WO1995004545A1 (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4243491A1 (de) * 1992-12-22 1994-06-23 Behringwerke Ag Verfahren zur Reinigung und Anreicherung von Rubella-Virus
BR112013000345B1 (pt) * 2010-07-07 2021-11-23 Artificial Cell Technologies, Inc Composição compreendendo partículas contendo epítopos de rsv
CN110684747B (zh) * 2018-07-06 2024-05-24 厦门大学 灭活及保存呼吸道合胞病毒的方法
EP4072582A4 (en) * 2019-12-10 2023-05-24 Repligen Corporation PROCESS FOR PREPARING VIRAL VECTORS
EP4281065A1 (en) 2021-01-20 2023-11-29 Alto Neuroscience, Inc. Enhancement of camp signaling as a combination drug strategy for the treatment of depression and related conditions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1188985A (en) * 1980-07-01 1985-06-18 Edward J. Stott Production of viral antigens
US4591505A (en) * 1982-04-14 1986-05-27 New York Blood Center, Inc. Process for inactivating hepatitis B virus
US4664912A (en) 1984-10-01 1987-05-12 Wiktor Tadeusz J Process for the large scale production of rabies vaccine
US4790987A (en) 1985-11-15 1988-12-13 Research Corporation Viral glycoprotein subunit vaccine
US4732683A (en) * 1986-12-02 1988-03-22 Biospectrum, Inc. Purification method for alpha interferon
EP0310316B1 (en) * 1987-09-28 1995-02-01 Beecham Inc. TGEV-virus of swine as a dog vaccine
US5200179A (en) * 1987-09-28 1993-04-06 Beecham Group P.L.C. Vaccine
US5223254A (en) * 1987-09-29 1993-06-29 Praxis Biologics, Inc. Respiratory syncytial virus: vaccines
GB8914968D0 (en) 1989-06-29 1989-08-23 Connaught Lab Production of virus and purification of viral envelope proteins for vaccine use
IL105456A (en) 1992-04-21 1996-12-05 American Home Prod Vaccines of attenuated respiratory syncytial virus

Also Published As

Publication number Publication date
CN1103603C (zh) 2003-03-26
AU7380194A (en) 1995-02-28
RU2142817C1 (ru) 1999-12-20
DE69409243D1 (de) 1998-04-30
CA2167274A1 (en) 1995-02-16
DE69409243T2 (de) 1998-08-06
AU677090B2 (en) 1997-04-10
ES2113670T3 (es) 1998-05-01
US7083795B1 (en) 2006-08-01
BR9407182A (pt) 1996-09-17
KR100402379B1 (ko) 2004-03-24
JP4053587B2 (ja) 2008-02-27
EP0714306B1 (en) 1998-03-25
CA2167274C (en) 2007-11-27
ATE164313T1 (de) 1998-04-15
EP0714306A1 (en) 1996-06-05
JPH09501912A (ja) 1997-02-25
WO1995004545A1 (en) 1995-02-16
CN1133013A (zh) 1996-10-09
GR3026619T3 (en) 1998-07-31
KR960703618A (ko) 1996-08-31

Similar Documents

Publication Publication Date Title
HU9401056D0 (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
BR9510263A (pt) Novo derivado de ciclodextrina processo para sua preparação utilização dos mesmos composição terapêutica e adjuvante para vacinas
WO2004001007A3 (en) Buffered formulations for concentrating antibodies and methods of use thereof
DK0427347T3 (da) Syntetiske peptider, der kan anvendes som universelle bærere til fremstilling af immunogene konjugater, og anvendelse deraf til udvikling af syntetiske vacciner
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
DE69534992D1 (de) Mutierendes enterotoxin als nichttoxisches orales adjuvans
HU229368B1 (en) Novel vaccine composition
ES2074950A1 (es) Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda.
FI905184A0 (fi) Kimeriska glykoproteiner som innehaoller immunogeniska delar av human parainfluensa-virus typ 3.
ATE179614T1 (de) Herpes simplex virus vp16 impfstoffe
SE8005824L (sv) Vaccin av hudparvovirus samt forfarande for dess framstellning
DK273384D0 (da) Levende adjuvansholdige vacciner og fremgangsmaader til fremstilling af saadanne vacciner
EP0480949B1 (en) Production of virus and purification of viral envelope proteins for vaccine use
DE69940406D1 (de) Ine rsv untereinheit zusammensetzung und ein influenzavirus präparat enthält
ATE164313T1 (de) Inaktivierte respiratorische synzytial-virus- impfstoffe
ES379641A1 (es) Procedimiento de produccion de antigenos inactivos para preparados farmaceuticos.
DE68923169D1 (de) Verwendung von fluor enthaltenden Pyridoncarbonsäure-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von HIV infektionen.
ATE354370T1 (de) Inaktivierte immunogene bakterielle ganzzell- zusammensetzungen
Stittelaar et al. Longevity of neutralizing antibody levels in macaques vaccinated with Quil A-adjuvanted measles vaccine candidates
WO1999053950A3 (en) Live vaccines and methods of treatment therewith
NO169820C (no) Fremgangsmaate for fremstilling av en mastittvaksine
van der Noordaa et al. Primary vaccination with an attenuated strain of vaccinia virus
AU554859B2 (en) Polymerized albumin vaccine
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
NL300073I1 (nl) Vaccin.